Vir Biotechnology, Inc 10-Q for FY2021 Q3
Vir Biotechnology, Inc. (VIR)
10-Q
2021-11-04
For: 2021-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Vir Biotechnology, Inc filed this 10-Q on November 4, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $103.62M
- up 5274.3% from $1.93M a year earlier
- Net income
- $110.43M
- compared with a net loss of $84.61M a year earlier
- Diluted EPS
- $0.82
- compared with -$0.67 a year earlier